Skip to main content
SteadySharesSteadySharesSteadyStShares
The market
MarketsDiscover
Follow the money
Super InvestorsPolitician TradesCrypto Desk
Yours
My WealthNews
Settings Sign in to save your work
Open
SteadySharesMarketsDiscoverSuper InvestorsMy WealthPoliticiansCryptoNews
DiscoverSRT3.DE
HealthcareGEREUR

Sartorius Aktiengesellschaft

€001234567890012345678900123456789.0012345678900123456789-1.2%
52w low (est.) €167.37€282.53 52w high (est.)
Market data · updated 4m ago
Peers
Market data
Market cap
EUR19.23B
52w range
EUR175.95 - EUR267.70
Beta
1.47
Sector
Healthcare
Data quality
96/100
Valuation
P/E ratio
103.1x
DCF fair value
EUR97.36
Margin of safety
-55.4%
Forward P/E
38.3x
PEG ratio
0.94
Dividend yield
0.30%
Quality & efficiency
Moat score
42/100
Return on equity
6.2%
Profit margin
4.6%
Debt / equity
1.11
Growth & analysts
Revenue growth
+1.8%
Analyst target
EUR267.37
Target upside
+22.4%
Analysts
19
Run the 10-point checklist before you buy How these numbers are made

About Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell culture solutions, including bioreactors and fermenters, cell culture reagents, supplements and matrices, nucleic acid and delivery solutions, cell culture media, and cell lines and buffers; and fluid management products. It also provides lab filtration and purification solutions, lab water purification systems, microtissue technologies, lab weighing, pipettes, tips and dispensers, microbiological testing solutions, lab data and fleet management software, and OEM solutions; and Process chromatography and filtration solutions. The company serves the life science research, biopharmaceutical manufacturing, cell and gene therapy, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.

Valuation

ValueGrowthProfitHealthIncome21QUALITY
Overall Rating
24
Sell
Sell

Derived from filed metrics · High confidence (96% of the inputs available)

Moat Score42
DCF Intrinsic Value
EUR97.36-55.4% downside

Moat, DCF and rating computed by our valuation engine (ported from the original Python model).

Fundamentals

Market Cap
EUR19.23B
P/E Ratio
103.1
Dividend Yield
0.30%
Revenue Growth
+1.8%
Profit Margin
4.6%
ROE
6.2%
Debt / Equity
1.11
Beta
1.47
vs Healthcare sector:P/E 103 vs 28 Moat 42 vs 7Yield 0.30% vs 0.3%

Statistics

Similar Stocks · Healthcare

LLY73
$920.00+0.7%
AZN.L72
£105.20+0.6%
UNH71
$492.10+1.6%
JNJ70
$146.20-0.2%

Latest News · SRT3.DE